Patent assignee · FR · COMPANY

CENTRE LEON BERARD

🏢 View company profile →
31Patents
30Active
31Granted
55Portfolio score

Filing activity: Dec 4, 2002 → Jul 7, 2023 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9376493B2 Antibodies directed against ICOS and uses thereof Chemistry; Metallurgy 22 Active
US7414024B2 Proteins with IL-6 inhibiting activity Human Necessities 21 Expired
US9676852B2 Antibodies directed against ICOS and uses thereof Chemistry; Metallurgy 6 Active
US10004888B2 Method for determining optimized parameters of a device generating a plurality of ultrasound beams focused in a region of interest Human Necessities 3 Active
US9975950B2 Antibodies directed against ICOS and uses thereof Chemistry; Metallurgy 3 Active
US9695247B2 Antibodies directed against ICOS for treating graft-versus-host disease Chemistry; Metallurgy 2 Active
US11130817B2 CD73 blocking agents Chemistry; Metallurgy 2 Active
US10633446B2 Antibodies directed against ICOS and uses thereof Chemistry; Metallurgy 1 Active
US11740243B2 Early and non invasive method for assessing a subject's risk of having pancreatic ductal adenocarcinoma and methods of treatment of such disease Human Necessities 1 Active
US11602327B2 Method and system for localizing a region of interest in a medium in which cavitation occurs Human Necessities 1 Active
US10533046B2 Anti-CK8 antibodies for use in the treatment of colorectal cancers Physics 1 Active
US10745482B2 Antibodies directed against ICOS and uses thereof Chemistry; Metallurgy 1 Active
US10180437B2 Predictive method for determining tissual radiosensitivity Physics 0 Active
US11579147B2 Use of VNN1 as a biomarker and a therapeutic target in sarcomas Physics 0 Active
US9683986B2 Treatment of cancer by inhibition of the MYD88/ERK MAP kinase interaction Physics 0 Active
US12140594B2 Early and non invasive method for assessing a subject's risk of having pancreatic ductal adenocarcinoma and methods of treatment of such disease Human Necessities 0 Active
US10197578B2 Predictive method of characterizing the radiosensitivity and tissular reaction of a patient to therapeutic ionizing radiation Physics 0 Active
US8709719B2 ZNF217 a new prognostic and predictive biomarker of recurrent invasive and metastatic phenotypes in breast cancer Chemistry; Metallurgy 0 Active
US10485516B2 Shear wave generation method, shear wave imaging method and thermal mapping or treating method utilizing such a generation method and installation for generating at least one shear wave Physics 0 Active
US10273306B2 Antibodies directed against ICOS for treating graft-versus-host disease Chemistry; Metallurgy 0 Active
US11384081B2 Benzoimidazole derivatives as anticancer agents Chemistry; Metallurgy 0 Active
US11555191B2 Inhibitor for use for preventing and/or treating an infection with hepatitis B virus Chemistry; Metallurgy 0 Active
US11180556B2 Antibodies directed against ICOS and uses thereof Chemistry; Metallurgy 0 Active
US11540806B2 Device and system for generating ultrasonic waves in a target region of a soft solid and method for locally treating a tissue Human Necessities 0 Active
US12371402B2 Mitochondrial activity inhibitors targeting tumoral metabolism Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.